Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Primary Care Respiratory Journal
  • View all journals
  • Search
  • Log in
  • Content Explore content
  • About the journal
  • Publish with us
  • RSS feed
  1. nature
  2. primary care respiratory journal
  3. articles
  4. article
The ADMIT series — Issues in Inhalation Therapy. 7) Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation technique
Download PDF
  • Article
  • Published: 02 August 2011

The ADMIT series — Issues in Inhalation Therapy. 7) Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation technique

  • Mariëlle EAC Broeders1,
  • Walter Vincken2 &
  • Lorenzo Corbetta3
  • on behalf of the ADMIT Working Group

Primary Care Respiratory Journal volume 20, pages 338–343 (2011)Cite this article

  • 2657 Accesses

  • 29 Citations

  • Metrics details

Abstract

Since inhalation therapy will probably remain the preferred route of treatment for patients with chronic obstructive pulmonary disease (COPD), it is important to provide helpful information that may assist physicians and nurses in selecting the appropriate device(s) for individual patients as well as prescribing the correct medication. In line with the GOLD guidelines, the Aerosol Drug Management Improvement Team (ADMIT) propose a three-part “therapy adjustment strategy”, which provides health care professionals with a way to monitor and check the delivery of inhaled medication. The strategy is a summation of the key principles behind the evidence-based management of stable COPD and exacerbations. It offers physicians a rapid and user-friendly overview of the requirements of COPD management starting with making the diagnosis and continuing with optimisation of therapy in follow-up appointments. It includes everything from check lists for disease assessment and recommendations for reducing risk factors to selecting the proper inhalers and continuous checking of compliance and correct inhaler technique. These practical COPD therapy adjustment algorithms have been used as part of an interactive online course developed by the ADMIT group (www.admit-online.info). The COPD “flash” video available at this web site offers suggestions on how to organise a complete doctor-patient consultation.

You have full access to this article via your institution.

Download PDF

Similar content being viewed by others

Pharmaceutical treatment status of patients with COPD in the community based on medical Internet of Things: a real-world study

Article Open access 10 May 2024

Knowledge, attitudes, and practices of inhalation device use among patients with chronic obstructive pulmonary disease

Article Open access 21 July 2025

Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunities  

Article 22 September 2025

Article PDF

Author information

Authors and Affiliations

  1. Department of Pulmonary Diseases, Jeroen Bosch Hospital 's-Hertogenbosch, The Netherlands

    Mariëlle EAC Broeders

  2. Respiratory Division, UZ Brussel, Brussels, Belgium

    Walter Vincken

  3. Università degli Studi di Firenze, Firenze, Italy

    Lorenzo Corbetta

Authors
  1. Mariëlle EAC Broeders
    View author publications

    Search author on:PubMed Google Scholar

  2. Walter Vincken
    View author publications

    Search author on:PubMed Google Scholar

  3. Lorenzo Corbetta
    View author publications

    Search author on:PubMed Google Scholar

Consortia

on behalf of the ADMIT Working Group

Corresponding author

Correspondence to Mariëlle EAC Broeders.

Ethics declarations

Competing interests

Marielle Broeders has acted as a consultant for Meda AB and GlaxoSmithKline.

Walter Vincken has acted as a consultant for Meda AB and spoken at conferences sponsored by Meda, Boehringer Ingelheim, GSK, Novartis and Menarini. WV has also received education grants from Altana/Nycomed, AstraZeneca, BI, GSK, Novartis, Pfizer, Meda and Chiesi.

Lorenzo Corbetta has acted as a consultant for GSK, AZ, BI/Pfizer, Merck Sharpe and Dohme, Meda, Novartis and UCB and spoken at conferences sponsored by Abbott, GSK, AZ, BI/Pfizer, Meda, Novartis, Zambon and UCB. LC has also received education grants from GSK, AZ, BI/Pfizer and research grants from GSK and AZ.

Conflicts of interest for all ADMIT members are listed at the end of the first paper in this series — see Dekhuijzen et al. Prim Care Respir J 2007;16(6):341–8.

Rights and permissions

Reprints and permissions

About this article

Cite this article

EAC Broeders, M., Vincken, W., Corbetta, L. et al. The ADMIT series — Issues in Inhalation Therapy. 7) Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation technique. Prim Care Respir J 20, 338–343 (2011). https://doi.org/10.4104/pcrj.2011.00062

Download citation

  • Received: 17 January 2011

  • Revised: 14 April 2011

  • Accepted: 12 May 2011

  • Published: 02 August 2011

  • Issue date: September 2011

  • DOI: https://doi.org/10.4104/pcrj.2011.00062

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

This article is cited by

  • Exploring General Practitioners’ Preferences and Experience with Respiratory Inhaler Devices

    • Biljana Cvetkovski
    • Charlotte Hespe
    • Sinthia Bosnic-Anticevich

    Pulmonary Therapy (2022)

  • Efficacy of an educational intervention in primary health care in inhalation techniques: study protocol for a pragmatic cluster randomised controlled trial

    • José Leiva-Fernández
    • Rubén L. Vázquez-Alarcón
    • Pilar Barnestein-Fonseca

    Trials (2016)

  • Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study

    • Sergi Pascual
    • Jan Feimer
    • Henry Chrystyn

    npj Primary Care Respiratory Medicine (2015)

  • Impact of multiple-dose versus single-dose inhaler devices on COPD patients’ persistence with long-acting β2-agonists: a dispensing database analysis

    • Job FM van Boven
    • Joost J van Raaij
    • Stefan Vegter

    npj Primary Care Respiratory Medicine (2014)

You have full access to this article via your institution.

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information

Publish with us

  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Primary Care Respiratory Journal (Prim Care Respir J)

ISSN 1475-1534 (online)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing